PharmaCompass – Grow Your Pharma Business Digitally

Market Place

$Dr. Reddy\'s Laboratories$

Market Place

All Enquiries

APIs

Dossiers // FDF

Contract Services

Excipients

Intermediates

Ask Us

Post an Enquiry

Various APIs needed in Ukraine

A company that focuses on research, development, manufacturing and marketing of various medicines & health products is looking for suppliers of Various APIs for development purpose.
1. Ph. Eur Grade Sodium Hyaluronate API
2. Ph. Eur Grade Sodium Chloride API

03 Oct 2022

Comment (3)
Reply

IP Grade Donepezil Hydrochloride API needed in India

A company that deals in the development & manufacturing of finished formulations is looking for suppliers of IP Grade Donepezil Hydrochloride API for commercial purpose. The suppliers must support this enquiry with CoA.

03 Oct 2022

Comment (1)

Reply
Aspartame (300 kg) API needed in India

A company that deals in the distribution of various pharmaceutical products is looking for suppliers of Aspartame (300 kg) API for commercial purpose. The suppliers must support this enquiry with CoA.

03 Oct 2022

Comment (2)
Reply

Manganese Sulfate API needed in Pakistan

A company that focuses on developing, manufacturing and marketing of branded generic & specialty drugs in respiratory, dermatology, anti-inflammatory, anesthetics, anti-infectives, anti-nauseants, anti-emetics, anti-ulcers, NSAIDs and ophthalmics therapeutic areas is looking for suppliers of Manganese Sulfate API for development purpose.

03 Oct 2022

Comment (1)

Reply
Creatine Monohydrate (10 MT) API needed in India

A company that deals in various pharmaceutical products is looking for suppliers of Creatine Monohydrate (10 MT) API for commercial purpose. The suppliers must support this enquiry with CoA.

03 Oct 2022

Comment (3)
Reply

Various APIs needed in Bahrain

A contract manufacturing organization that specializes in the manufacturing of parenteral formulations is looking for suppliers of Various APIs for development purpose. The suppliers must support this enquiry with CEP (optional), GMP & CoA.
1. Ph. Eur./ USP / Injectable Grade & Micronized Ketoprofen (180 g) API
2. USP/ Injectable Grade Levofloxacin Hemihydrate (25 g) API
3. USP/ Injectable Grade Lidocaine Hydrochloride (110 g) API
4. USP/ Injectable Grade Linezolid (15 g) API
5. Injectable Grade Lornoxicam API

03 Oct 2022

Comment

Reply
Tender// Various Finished Dosage Formulations needed in Poland

District Hospital in Chrzanow is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 28-Oct-2022.
1. Cinacalcet (30 mg) Tablets. The required quantity is 70,560 units.
2. Teriflunomide (14 mg) Tablets. The required quantity is 3,416 units.
3. Eliglustat (84 mg) Capsules. The required quantity is 1,568 units.

03 Oct 2022

Comment (1)
Reply

Tender// Various Finished Dosage Formulations needed in Latvia

Sia CGSU Klinika is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 4-Nov-2022.
1. Omeprazole (20 mg) Tablets. The required quantity is 40,000 units.
2. Acetylsalicylic Acid (100 mg) Tablets. The required quantity is 10,300 units.
3. Furosemide (10 mg/ ml) Solution for Injections. The required quantity is 20,000 units.
4. Ceftriaxone (1000 mg) Powder for Solution for Injections. The required quantity is 22,000 units.

01 Oct 2022

Comment (2)

Reply
Tender// Various Finished Dosage Formulations needed in Poland

Mazowieckie Centrum Rehabilitacji Stocer Sp. z oo is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 27-Oct-2022.
1. Metamizole Sodium (1 g/ 2 ml) Injections. The required quantity is 6,300 units.
2. Paracetamol (500 mg) Tablets. The required quantity is 1,190 units.
3. Pantoprazole (20 mg) Tablets. The required quantity is 1,130 units.

30 Sep 2022

Comment (2)
Reply

Alprostadil (20 mcg/ ml) Injections needed in Ukraine

A company that focuses on research, development, manufacturing and marketing of various medicines & health products is looking for suppliers of Alprostadil (20 mcg/ ml) Injections for commercial purpose. The required quantity is 10,000 packs (10 units/ pack). The suppliers must support this enquiry with GMP & PICS.

29 Sep 2022

Comment (5)

Reply
Looking for a CMO for Encapsulation of Liquid Fat in HGC

A company that focuses on research, development, manufacturing and marketing of natural nutritional supplement formulas is looking for a CMO for the Encapsulation of liquid fat in normal or vegan hard gelatin capsules. The process of encapsulation should be done without heat. Initially, small quantities are required & later on large quantities. The geographical preference for CMO is UK, Israel & Europe.

03 Sep 2022

Comment (4)
Reply

Looking for an EU or WHO-GMP certified CMO to Manufacture OSDs

A Turkish-based company that focuses on manufacturing a wide range of finished dosage forms in the field of natural cannabinoids, opioid medications, cosmeceuticals & nutraceuticals is looking for an EU GMP or WHO GMP certified CMO to manufacture OSDs using controlled substances or opioid APIs. The required dosage form is tablets, capsules & syrups. The geographical preference for CMO is Europe & India.

01 Sep 2022

Comment (8)

Reply
Looking for a CDMO for Development of Soft Gel Capsules

A company that focuses on the manufacturing of soft gelatine capsules and gelatine enrobed tablets is looking for a GMP-approved CDMO for the Development of Soft Gel Capsules. The required shape of capsules is oval & round. The required packaging is in bottles & strips. The project will launch in 2023.

31 Aug 2022

Comment (4)
Reply

Looking for an EU or WHO-GMP certified CMO to Manufacture APIs

A Turkish-based company that focuses on manufacturing a wide range of finished dosage forms in the field of natural cannabinoids, opioid medications, cosmeceuticals & nutraceuticals is looking for an EU GMP or WHO GMP certified CMO to manufacture controlled substances or opioid APIs. The company will provide n-1 product to the service provider. The geographical preference for CMO is Europe & India.

08 Aug 2022

Comment (7)

Reply
Vinylpyrrolidone (800 kg - 1 MT) Excipient needed in France

A company based in Denmark that specializes in marketing and distribution of various finished formulations is looking for suppliers of Vinylpyrrolidone (800 kg - 1 MT) Excipient for commercial purpose. The suppliers must support this enquiry with CoA.

03 Oct 2022

Comment
Reply

Various Excipients needed in Peru

A company that focuses on research, development and manufacturing of ophthalmic products is looking for suppliers of Various Excipients for commercial purpose. The suppliers must support this enquiry with CoA.
1. Hydroxypropyl Guar Excipient
2. Dextran Excipient
3. Hypromellose Excipient

03 Oct 2022

Comment

Reply
Various Excipients needed in Russia

A multinational pharmaceutical manufacturing company based in India that has over 200 products covering the whole spectrum of disease areas spanning gastroenterology, oncology, pain management, cardiovascular, dermatology, urology, nephrology, rheumatology, and diabetes is looking for suppliers of Various Excipients for development purpose.
1. Hydroxy Propyl Bispalmitamide MEA (CAS 211184-47-3) Excipient
2. Polyamide 5 Excipient
3. Filagrinol Excipient

30 Sep 2022

Comment (7)
Reply

IP Grade Glycerin (1 MT) Excipient needed in India

A company that deals in the distribution of various pharmaceutical products is looking for suppliers of IP Grade Glycerin (1 MT) Excipient for commercial purpose. The suppliers must support this enquiry with CoA.

29 Sep 2022

Comment (4)

Reply

#SpeakPharma Interview

All Interviews

“Our API is a critical resource that’s managed in an innovative, competitive way”

All Interviews

“Euroapi is a growth story based on fast-growing CDMO activity and greater focus on existing portfolio”

Impressions: 2112

More than two years ago, Sanofi had announced the creation of a standalone company that will combine its commercial and development activities in active pharmaceutical ingredients (API) with six of its European production sites in France, Italy, Germ...

#SpeakPharma with PharmaCompass

20 Jun 2022

Share

#PharmaFlow Data Compilation & Company Tracker

All Data Compilations

FDA braces for user fee reauthorization delay even as DMF submissions rise in H1 2022

All Data Compilations

Neurology Newsmakers: Big pharma forges deals to find cures for CNS disorders

Impressions: 472

This week, we look at the global market for neurological disorder drugs, which has been growing at a healthy rate of 5.9 percent per annum. There are several kinds of neurology disorders, such as epilepsy, Alzheimer’s disease, Parkinson’s...

#PharmaFlow by PharmaCompass

29 Sep 2022

Share

#PipelineProspector Monthly Stock Recap

All PipelineProspector

All Monthly Recap

Pipeline Prospector Aug 2022: US law to curb inflation spooks big pharma stocks

Impressions: 1607

Biotech stocks have been looking up since June this year. The trend continued through August with the Nasdaq Biotechnology Index (NBI) rising 0.6 percent to US$ 3,861. In July, it had gained 2 percent. Similarly, the S&P Biotechnology Select In...

#PipelineProspector by PharmaCompass

08 Sep 2022

Share

#Phispers Weekly News Recap

All Phispers

Bluebird ousts its own gene therapy approved last month as world’s costliest; Catalent hit by FDA’s Form 483

All Weekly Recap

Biogen-Eisai’s Alzheimer’s med shows benefit in late-stage trial; Lynparza’s ovarian cancer nod withdrawn

Impressions: 1268

This week, Phispers brings you news of a rare success — after the failure of Aduhelm, Biogen and Eisai said their experimental Alzheimer’s disease drug, lecanemab, was successful in slowing down the progress of the brain-wasting disease i...

#Phispers by PharmaCompass

29 Sep 2022

Share

News

Latest pharma news

Pharma news by category

All product launches & approvals

All quality compliance alerts

America

India

Europe

Asia

Generics

APIs

Quality

Science

Rare Diseases

Others

All News

Merck celebrates another win in Januvia patent battle against Viatris

ENPTS

01 Oct 2022

Share
Ocaliva fails NASH trial just as Intercept charts path toward FDA application

FIERCEPHARMA

01 Oct 2022

Grow Your Pharma Business Digitally

Market Place All Enquiries APIs Dossiers // FDF Contract Services Excipients Intermediates

#SpeakPharma Interview All Interviews

“Euroapi is a growth story based on fast-growing CDMO activity and greater focus on existing portfolio”

#PharmaFlow Data Compilation & Company Tracker All Data Compilations

Neurology Newsmakers: Big pharma forges deals to find cures for CNS disorders

#PipelineProspector Monthly Stock Recap All PipelineProspector

Pipeline Prospector Aug 2022: US law to curb inflation spooks big pharma stocks

#Phispers Weekly News Recap All Phispers

Biogen-Eisai’s Alzheimer’s med shows benefit in late-stage trial; Lynparza’s ovarian cancer nod withdrawn

News Latest pharma news Pharma news by category All product launches & approvals All quality compliance alerts America India Europe Asia Generics APIs Quality Science Rare Diseases Others

Merck celebrates another win in Januvia patent battle against Viatris

Ocaliva fails NASH trial just as Intercept charts path toward FDA application

Market Place

All Enquiries

APIs

Dossiers // FDF

Contract Services

Excipients

Intermediates

#SpeakPharma Interview

All Interviews

#PharmaFlow Data Compilation & Company Tracker

All Data Compilations

#PipelineProspector Monthly Stock Recap

All PipelineProspector

#Phispers Weekly News Recap

All Phispers

News

Latest pharma news

Pharma news by category

All product launches & approvals

All quality compliance alerts

America

India

Europe

Asia

Generics

APIs

Quality

Science

Rare Diseases

Others